First clinical experience with belzutifan in von Hippel–Lindau disease associated CNS hemangioblastoma

por Dhawan, Andrew, Peereboom, David M, Stevens, Glen HJ
Publicado 2022

Hyperosmolar and methotrexate therapy avoiding surgery in the acute presentation of primary central nervous system lymphoma

por Lee, Bryan S., Juthani, Rupa G., Healy, Andrew T., Peereboom, David M., Recinos, Violette M.
Publicado 2014

Novel Therapeutic Approaches in Neoplastic Meningitis

por Khosla, Atulya Aman, Saxena, Shreya, Ozair, Ahmad, Venur, Vyshak Alva, Peereboom, David M., Ahluwalia, Manmeet S.
Publicado 2022

Secondary somatic glioblastoma arising from a mature ovarian cystic teratoma in a patient with underlying Li-Fraumeni syndrome

por Bussies, Parker L., Chau, Danielle B., Hunt, Jonathan T., Policarpio-Nicolas, Maria Luisa C., Friedman, Cameron, McKenney, Jesse K., Yeaney, Gabrielle A., Peereboom, David M., Beffa, Lindsey
Publicado 2023

First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases

por Tatineni, Vineeth, O’Shea, Patrick J., Ozair, Ahmad, Khosla, Atulya A., Saxena, Shreya, Rauf, Yasmeen, Jia, Xuefei, Murphy, Erin S., Chao, Samuel T., Suh, John H., Peereboom, David M., Ahluwalia, Manmeet S.
Publicado 2023

Endoglin inhibitor TRC105 with or without bevacizumab for bevacizumab-refractory glioblastoma (ENDOT): a multicenter phase II trial

por Ahluwalia, Manmeet S., Rogers, Lisa R., Chaudhary, Rekha, Newton, Herbert, Ozair, Ahmad, Khosla, Atulya A., Nixon, Andrew B., Adams, Bonne J., Seon, Ben K., Peereboom, David M., Theuer, Charles P.
Publicado 2023

Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010–2019 Retrospective Cohort Study

por Tatineni, Vineeth, O’Shea, Patrick J., Saxena, Shreya, Khosla, Atulya A., Ozair, Ahmad, Kotecha, Rupesh R., Jia, Xuefei, Rauf, Yasmeen, Murphy, Erin S., Chao, Samuel T., Suh, John H., Peereboom, David M., Ahluwalia, Manmeet S.
Publicado 2023

Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma

por Schönthal, Axel H, Peereboom, David M, Wagle, Naveed, Lai, Rose, Mathew, Anna J, Hurth, Kyle M, Simmon, Vincent F, Howard, Steven P, Taylor, Lynne P, Chow, Frances, da Fonseca, Clovis O, Chen, Thomas C
Publicado 2021

Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression

por Alban, Tyler J., Bayik, Defne, Otvos, Balint, Rabljenovic, Anja, Leng, Lin, Jia-Shiun, Leu, Roversi, Gustavo, Lauko, Adam, Momin, Arbaz A., Mohammadi, Alireza M., Peereboom, David M., Ahluwalia, Manmeet S., Matsuda, Kazuko, Yun, Kyuson, Bucala, Richard, Vogelbaum, Michael A., Lathia, Justin D.
Publicado 2020

Primary central nervous system lymphoma: Inter‐compartmental progression

por Raval, Vishal, Binkley, Elaine, Aronow, Mary E., Valenzuela, Juan, Peereboom, David M., Wei, Wei, Srivastava, Sunil, Davanzo, Jaqueline, Boldt, Herbert Culver, McGarrey, Mark P., Papaliodis, George N., Sobrin, Lucia, Kim, Ivana K., Vavvas, Dimitrios G., Eliott, Dean, Nayak, Lakshmi, Dodds, Emilio, Marco del Pont, Francisco, Singh, Arun D.
Publicado 2022

Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial

por Nassiri, Farshad, Patil, Vikas, Yefet, Leeor S., Singh, Olivia, Liu, Jeff, Dang, Rachel M. A., Yamaguchi, Takafumi N., Daras, Mariza, Cloughesy, Timothy F., Colman, Howard, Kumthekar, Priya U., Chen, Clark C., Aiken, Robert, Groves, Morris D., Ong, Shirley S., Ramakrishna, Rohan, Vogelbaum, Michael A., Khagi, Simon, Kaley, Thomas, Melear, Jason M., Peereboom, David M., Rodriguez, Analiz, Yankelevich, Maxim, Nair, Suresh G., Puduvalli, Vinay K., Aldape, Kenneth, Gao, Andrew, López-Janeiro, Álvaro, de Andrea, Carlos E., Alonso, Marta M., Boutros, Paul, Robbins, Joan, Mason, Warren P., Sonabend, Adam M., Stupp, Roger, Fueyo, Juan, Gomez-Manzano, Candelaria, Lang, Frederick F., Zadeh, Gelareh
Publicado 2023